| Primary |
| Drug Use For Unknown Indication |
30.1% |
| Product Used For Unknown Indication |
16.9% |
| Maternal Exposure Timing Unspecified |
15.7% |
| Epilepsy |
12.0% |
| Bipolar Disorder |
6.0% |
| Intentional Overdose |
4.8% |
| Pneumonia |
4.8% |
| Anaesthesia |
2.4% |
| Bipolar I Disorder |
2.4% |
| Schizoaffective Disorder |
2.4% |
| Mental Disorder |
1.2% |
| Suicide Attempt |
1.2% |
|
| Blood Prolactin Increased |
7.7% |
| Drug Interaction |
7.7% |
| Habitual Abortion |
7.7% |
| Shock |
7.7% |
| Tremor |
7.7% |
| Weight Decreased |
7.7% |
| Electrocardiogram Qt Prolonged |
3.8% |
| Gestational Diabetes |
3.8% |
| Lipase Decreased |
3.8% |
| Memory Impairment |
3.8% |
| Neonatal Tachypnoea |
3.8% |
| Osteonecrosis |
3.8% |
| Oxygen Supplementation |
3.8% |
| Respiratory Depression |
3.8% |
| Soft Tissue Inflammation |
3.8% |
| Somnolence |
3.8% |
| Spina Bifida |
3.8% |
| Suicidal Ideation |
3.8% |
| Transient Tachypnoea Of The Newborn |
3.8% |
| Tubulointerstitial Nephritis |
3.8% |
|
| Secondary |
| Epilepsy |
37.9% |
| Drug Use For Unknown Indication |
23.4% |
| Product Used For Unknown Indication |
7.1% |
| Pneumonia |
4.7% |
| Depression |
4.1% |
| Bipolar Disorder |
3.6% |
| Sleep Disorder |
3.0% |
| Prophylaxis |
2.4% |
| Reflux Oesophagitis |
2.4% |
| Convulsion |
2.1% |
| Hypothyroidism |
2.1% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
1.5% |
| Bipolar I Disorder |
0.9% |
| Drug Exposure During Pregnancy |
0.9% |
| Mental Disorder |
0.9% |
| Migraine |
0.9% |
| Dementia Alzheimer's Type |
0.6% |
| Diabetes Mellitus |
0.6% |
| Hypertension |
0.6% |
| Prophylaxis Of Neural Tube Defect |
0.6% |
|
| Spina Bifida |
12.3% |
| Weight Decreased |
12.3% |
| Tremor |
9.2% |
| Renal Fusion Anomaly |
7.7% |
| Suicide Attempt |
7.7% |
| Weight Increased |
7.7% |
| Status Epilepticus |
6.2% |
| Transaminases Increased |
6.2% |
| Memory Impairment |
4.6% |
| Unintended Pregnancy |
4.6% |
| Neutropenia |
3.1% |
| Suicidal Ideation |
3.1% |
| Tachycardia |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Accidental Exposure |
1.5% |
| Confusional State |
1.5% |
| Drug Exposure During Pregnancy |
1.5% |
| Drug Level Decreased |
1.5% |
| Exposure During Pregnancy |
1.5% |
| General Physical Health Deterioration |
1.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.6% |
| Epilepsy |
19.4% |
| Depression |
7.4% |
| Hiv Infection |
6.7% |
| Schizoaffective Disorder |
6.7% |
| Schizophrenia, Paranoid Type |
4.2% |
| Hypertension |
3.9% |
| Prophylaxis |
3.9% |
| Bipolar Disorder |
2.5% |
| Diabetes Mellitus |
2.1% |
| Psychotic Disorder |
1.8% |
| Blood Cholesterol Increased |
1.4% |
| Eczema |
1.4% |
| Partial Seizures |
1.4% |
| Polyneuropathy |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Reflux Oesophagitis |
1.4% |
| Restlessness |
1.4% |
| Antiviral Prophylaxis |
1.1% |
| Erythema |
1.1% |
|
| Therapeutic Response Unexpected With Drug Substitution |
12.1% |
| Tachycardia |
6.9% |
| Toxic Epidermal Necrolysis |
6.9% |
| Transaminases Increased |
6.9% |
| Lactose Intolerance |
5.2% |
| Leukopenia |
5.2% |
| Somnolence |
5.2% |
| Syncope |
5.2% |
| Urinary Incontinence |
5.2% |
| Visual Disturbance |
5.2% |
| Zinc Deficiency |
5.2% |
| Aggression |
3.4% |
| Deep Vein Thrombosis |
3.4% |
| Drug Interaction |
3.4% |
| Electrocardiogram Qt Prolonged |
3.4% |
| Mania |
3.4% |
| Oedema |
3.4% |
| Paranoia |
3.4% |
| Rash |
3.4% |
| Renal Failure |
3.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Depression |
34.1% |
| Epilepsy |
11.4% |
| Schizoaffective Disorder |
4.5% |
|
| Transaminases Increased |
57.7% |
| Electrocardiogram Qt Prolonged |
15.4% |
| Hypokalaemia |
7.7% |
| Enuresis |
3.8% |
| Leukopenia |
3.8% |
| Pancytopenia |
3.8% |
| Pneumonia |
3.8% |
| Shock |
3.8% |
|
